The Mayo Clinic Center for Regenerative Biotherapeutics’ biomanufacturing capabilities help healthcare teams deliver next-generation treatments and cures for patients.

If you've ever noticed how memories from the same day seem connected while events from weeks apart feel separate, a new study ...

The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.

BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more than ...

Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen ...

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer.

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast ...

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative ...

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor ...

This study on mouse Ly49 receptors expressed on natural killer (NK) cells shows that Ly49A, in the presence of the corresponding MHC class I allele, can lead to NK cell licensing, thereby providing ...

Dendritic cells and macrophages were injected at the bottom ... First, we identified α-2 adrenergic receptor agonists as a novel regulatory pathway for tumors, capable of effectively improving and ...